Djay J. Wieczorek

Djay J. Wieczorek

Auto-generated profile, based on publicly available information

Djay J. Wieczorek

Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176 USA; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199 USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Medical Dosimetry
Verified
Journal Article
Open access
DWD Jay Wieczorek
D Jay Wieczorek
RKRupesh Kotecha
Rupesh Kotecha
MHMatthew D. Hall
Matthew D. Hall
MTMartin C. Tom
Martin C. Tom
SDStephen Davis
Stephen Davis
RTRanjini Tolakanahalli
Ranjini Tolakanahalli
To compare stereotactic radiosurgery (SRS) plan quality metrics of manual forward planning (MFP) and Elekta Fast Inverse Planning™ (FIP)-based inversely optimized plans for patients treated with Gamma Knife®. Clinically treated, MFP SRS plans for 100 consecutive patients (115 lesions; 67 metastatic and 48 benign) were replanned with the FIP dose optimizer based on a convex linear programming formulation. Comparative plans were generated to match or exceed the following metrics in order of importance: Target Coverage (TC), Paddick Conformity Index (PCI), beam-on time (BOT), and Gradient Index (GI). Plan quality metrics and delivery parameters between MFP and FIP were compared for all lesions and stratified into subgroups for further analysis. Additionally, performance of FIP for multiple punctate (<4 mm) metastatic lesions on a subset of cases was investigated. A Wilcoxon signed-rank test for non-normal distributions was used to assess the statistical differences between the MFP and FIP treatment plans. Overall, 76% (87/115) of FIP plans showed a statistically significant improvement in plan quality compared to MFP plans. As compared to MFP, FIP plans demonstrated an increase in the median PCI by 1.1% (p<0.01), a decrease in GI by 3.7% (p< 0.01), and an increase in median number of shots by 74% (p< 0.01). TC and BOT were not statistically significantly different between MFP and FIP plans (p>0.05). FIP plans showed a statistically significant increase in use of 16 mm (p< 0.01) and blocked shots (p< 0.01), with a corresponding decrease in 4 mm shots (p< 0.01). Use of multiple shots per coordinate was significantly higher in FIP plans (p<0.01). The FIP optimizer failed to generate a clinically acceptable plan in 4/115 (3.5%) lesions despite optimization parameter changes. The mean optimization time for FIP plans was 5.0 min (Range: 1.0 - 10.0 min). In the setting of multiple punctate lesions, PCI for FIP was significantly improved (p<0.01) by changing the default low-dose/BOT penalty optimization setting from a default of 50/50 to 75-85/40. FIP offers a significant reduction in manual effort for SRS treatment planning while achieving comparable plan quality to an expert planner-substantially improving overall planning efficiency. FIP plans employ a non-intuitive increased use of blocked sectors and shot-in-shot technique to achieve high quality plans. Several FIP plans failed to achieve clinically acceptable treatments and warrant further investigation.

16 September 2023 in Brachytherapy
Verified
Journal Article
Closed access
Tugce KutukTugce Kutuk
Tugce Kutuk
RTRanjini Tolakanahalli
Ranjini Tolakanahalli
VCVibha Chaswal
Vibha Chaswal
Sreenija YarlagaddaSreenija Yarlagadda
Sreenija Yarlagadda
RHRoberto Herrera
Roberto Herrera
RKRupesh Kotecha
Rupesh Kotecha

3 August 2024 in Brachytherapy
Verified
Journal Article
Closed access
Tugce KutukTugce Kutuk
Tugce Kutuk
RKRupesh Kotecha
Rupesh Kotecha
RHRoberto Herrera
Roberto Herrera
DWD Jay J. Wieczorek
D Jay J. Wieczorek
ZFZachary W. Fellows
Zachary W. Fellows
RTRanjini Tolakanahalli
Ranjini Tolakanahalli

6 November 2025 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
Sreenija YarlagaddaSreenija Yarlagadda
Sreenija Yarlagadda
RTRanjini Tolakanahalli
Ranjini Tolakanahalli
YZYanjia Zhang
Yanjia Zhang
DWDjay J. Wieczorek
Djay J. Wieczorek
TBTatiana Bejarano
Tatiana Bejarano
RKRupesh Kotecha
Rupesh Kotecha

29 September 2025 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
EAEYUB YASAR AKDEMIR
EYUB YASAR AKDEMIR
JDJoseph DiStefano
Joseph DiStefano
KAKevin J. Abrams
Kevin J. Abrams
CSCharif Sidani
Charif Sidani
MCMargaret C. Chaneles
Margaret C. Chaneles
RKRupesh Kotecha
Rupesh Kotecha

21 September 2025 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
YLYongsook C. Lee
Yongsook C. Lee
WRWilliam Romaguera
William Romaguera
SDStephen D. Davis
Stephen D. Davis
DWD Jay Wieczorek
D Jay Wieczorek
VCVibha Chaswal
Vibha Chaswal
AGAlonso N. Gutierrez
Alonso N. Gutierrez
Purpose: This work reports on results of periodic machine quality assurance (QA) tests for our superficial radiation therapy (SRT) unit (SRT‐100 Vision) performed for the first three‐ and half‐ year. Methods: Results of machine warm‐up, dosimetry, mechanical, safety and imaging QA tests for our SRT‐100 Vision unit were reviewed and analyzed. Dosimetry tests included output constancy, backup timer, timer accuracy, beam quality (half value layer [HVL]), applicator factors (AFs), absolute output calibration, output constancy with varying x‐ray tube head rotation, output reproducibility, output linearity, timer and end‐effect error, percent depth dose (PDD) verification and congruence between radiation field and applicator size. Mechanical tests encompassed unit stability as well as applicator integrity and indicators. Safety tests consisted of visual and audio monitors, beam‐on indicator, interlocks, and energy/filter indicators. Imaging tests for ultrasound covered functional check, spatial integrity, and image quality check. The QA tests were performed for three kilovoltage (kV) x‐ray energies (50, 70, and 100 kV p ) and six applicators (1.5, 2.0, 2.5, 3.0, 4.0, and 5.0 cm in diameter). Results: Daily mandatory machine warm‐up was successfully completed on each day of treatment. The results of all dosimetry tests for three energies were within the recommended tolerance. Daily, and monthly outputs and annual absolute outputs were < ± 3.0%, < ± 2.0%, and < ± 1.3%, respectively. Backup timer displayed timer set ± 0.0%. Timer accuracy was < ± 1.0 sec. HVLs and AFs were < ± 1.1% and < ± 0.3%, respectively. Outputs for different head angles were < ± 1.0% and output reproducibility was within 0.1%. Output linearity was < ± 0.6% and end‐effect errors were < ± 0.0006 min. PDDs were < ± 2.2%. Congruence was < ± 0.5 mm. Monthly mechanical tests confirmed mechanical robustness of our unit. Daily safety features were verified to be functional each day. Monthly imaging tests for ultrasound showed good functionality, image quality, and spatial integrity meeting the set tolerance. Conclusions: The QA results demonstrated high performance and stability of our SRT‐100 Vision unit over the first three and a half years of operation.